You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

squamous cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma, the Nasal Cavity, Paranasal Sinuses Trial in Houston (Pembrolizumab, Docetaxel, Cisplatin)

Recruiting
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer Trial in Boise (30% ascorbic acid in DMSO)

Recruiting
  • Squamous Cell Cancer
  • +3 more
  • 30% ascorbic acid in DMSO
  • Boise, Idaho
    Center for Biomedical Research,Inc.
Jul 2, 2023

PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

Not yet recruiting
  • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
  • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
  • (no location specified)
Sep 24, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Recruiting
  • Oral Cancer
  • +2 more
  • Biopsy Specimens Histopathology
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Institute of Pathology
Jun 22, 2023

People Living With HIV, Oral and Oropharyngeal Cancer, and

Not yet recruiting
  • HIV Infections
  • +2 more
  • Group Meeting (Focus Group)
  • Questionnaires
  • San Francisco, California
    University of California, San Francisco
Sep 20, 2023

Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

Recruiting
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • ELISA
  • Fayoum, Egypt
    Fayoum University
Sep 8, 2023

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

Recruiting
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • IMRT
  • Nivolumab
  • Atlanta, Georgia
  • +3 more
Jan 10, 2023

Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

Not yet recruiting
  • Non Squamous Non Small Cell Lung Cancer
  • EGFR Positive Non-small Cell Lung Cancer
  • Toripalimab plus Chemotherapy
  • (no location specified)
Jul 28, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Esophageal Cancer Trial in Wuhan

Recruiting
  • Esophageal Cancer
    • Wuhan, Hubei, China
      Renmin hosptial of Wuhan University
    Jun 7, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +3 more
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    May 17, 2023

    Stage T3 Squamous Cell Carcinomas of the Scalp

    Active, not recruiting
    • Squamous Cell Carcinoma
    • +2 more
      • Maastricht, Netherlands
        Ellen Oyen
      Aug 3, 2023

      Narrow Band Imaging Bronchoscopy in Detecting Bronchial Squamous

      Enrolling by invitation
      • Pulmonary Cancer
      • Lung Cancer
        • Jakarta Pusat, DKI Jakarta, Indonesia
          Faculty of Medicine
        Oct 27, 2023

        Advanced Squamous Non Small Cell Lung Cancer Trial (AK112, Carboplatin, Paxlitaxel, Tislelizumab, Carboplatin, Paxlitaxel)

        Not yet recruiting
        • Advanced Squamous Non Small Cell Lung Cancer
        • AK112, Carboplatin, Paxlitaxel
        • Tislelizumab, Carboplatin, Paxlitaxel
        • (no location specified)
        Apr 21, 2023

        Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinomas
        • +3 more
        • chemotherapy combined with PD-1 inhibitors
        • (no location specified)
        Nov 17, 2022

        Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Locally Advanced Operable
        • Guangzhou, Guangdong, China
        • +1 more
        Sep 4, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023

        Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

        Active, not recruiting
        • Esophageal Cancer
        • follow up
        • Guangzhou, Guangdong, China
          Jianhua Fu
        Sep 24, 2023

        Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)

        Recruiting
        • Squamous Cell Carcinoma
        • Head and Neck Cancer
        • Intensity-modulated radiotherapy
        • Magnetic Resonance Guidance
        • Tampa, Florida
          Moffitt Cancer Center
        Nov 13, 2023